Nurse Practitioner in Bismarck, AR Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Melissa S Keesee, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 213 Cable Ln, Bismarck, AR 71929 Phone: 501-318-3120 |
Ms. Angela D Suttle, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 6679 Highway 7, Bismarck, AR 71929 Phone: 501-865-2855 Fax: 501-868-2868 |
Miranda Victoria Franco, MSN, APRN, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 6679 Highway 7, Bismarck, AR 71929 Phone: 501-865-2855 Fax: 501-865-2868 |
Jakeeli K. Kersey, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 6679 Highway 7, Bismarck, AR 71929 Phone: 501-865-2855 Fax: 501-865-2868 |
News Archive
Innovative new devices that facilitate IA treatment improve outcomes, decrease mortality rates
In the last decade, Intra-Arterial (IA) stroke therapy (a technique in which thrombolytic agents and devices are passed through the arteries directly to the clot site) has gained notable momentum as an effective and safe treatment option for patients.
Researchers find way to trigger 'virus alert' that may help boost drug's ability to prevent cancer cells
Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells' ability to avoid detection and destruction by the immune system.
New way to awaken paternal Ube3a allele linked with Angelman syndrome
Results of a new study from the University of North Carolina at Chapel Hill may help pave the way to a treatment for a neurogenetic disorder often misdiagnosed as cerebral palsy or autism.
ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, today announced additional data from its Phase I clinical trial evaluating ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme (GBM).
IPSY programme leads children to say 'no' to cigarettes and alcohol
Their numbers are rising, but their age is dropping: children and young adults who drink so much that they have to go to the hospital. Binge-drinking is sadly fashionable amongst the under 20-year-olds. But how can adolescents be effectively protected from alcohol and substance abuse?
› Verified 4 days ago